thiazoles has been researched along with Lymphoma, Primary Effusion in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jäger, W; Karsten, CB; Kati, S; Ojala, PM; Pietrek, M; Santag, S; Sarek, G; Schulz, TF; Steinemann, D | 1 |
1 other study(ies) available for thiazoles and Lymphoma, Primary Effusion
Article | Year |
---|---|
Recruitment of the tumour suppressor protein p73 by Kaposi's Sarcoma Herpesvirus latent nuclear antigen contributes to the survival of primary effusion lymphoma cells.
Topics: Antigens, Viral; Apoptosis; Binding Sites; Catechols; Cell Survival; DNA Damage; DNA-Binding Proteins; HEK293 Cells; HeLa Cells; Humans; Imidazoles; Lymphoma, Primary Effusion; Nuclear Proteins; Piperazines; Thiazoles; Tumor Protein p73; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2013 |